Pharma Journalist 8801 posts 0 comments

Novaremed AG (Novaremed), a clinical-stage Swiss biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has cleared an Investigational New Drug (IND)…
Read More...

Linnaeus Therapeutics, Inc. (Linnaeus) announced that it has entered into a clinical collaboration agreement with Merck to evaluate the combination of its lead investigational product…
Read More...

Sanofi Pasteur, the vaccines global business unit of Sanofi, and Translate Bio, a clinical-stage messenger RNA (mRNA) therapeutics company, have agreed to expand their existing 2018…
Read More...

Gilead Sciences, Inc. announced that for $275 million the company will acquire a 49.9 percent equity interest in Pionyr Immunotherapeutics Inc., a privately held company developing…
Read More...

Century Therapeutics announced its acquisition of Empirica Therapeutics to leverage its iPSC-derived allogeneic cell therapies against glioblastoma (GBM). “We are pleased to welcome…
Read More...

SMi Reports: Lynne Ensor the conference chair has invited fellow microbiologists to join her at upcoming SMi’s 3rd Annual Pharmaceutical Microbiology East Coast Conference. Lynne…
Read More...

Agenus Inc. announced that it has entered into an agreement with Betta Pharmaceuticals, a top Chinese pharmaceutical company focusing on the development of innovative oncology…
Read More...

Sarepta Therapeutics, Inc. and Codiak BioSciences, Inc. announced a global research and option agreement to design and develop engineered exosome therapeutics to deliver gene therapy,…
Read More...

Piramal Enterprises Limited's (PEL) Pharma Solutions business, a leading Contract Development and Manufacturing Organization (CDMO), announced that the Company has entered into an…
Read More...

Ascentage Pharma announced a clinical collaboration with Acerta Pharma, the hematology research and development center of excellence of AstraZeneca. Under the terms of the…
Read More...